As access and reimbursement becomes more complex in Europe, pharmaceutical manufacturers’ Medical Affairs (MA) organizations have a more important role to play. This paper examines that role and illuminates some of the unique factors manufacturers should bear in mind when developing an MA launch readiness plan in Europe for the first time. Article available for download here. (Source: Campbell Alliance).
You are here: / / Three Keys to Developing a Medical Affairs Launch Readiness Plan in Europe